Le Lézard
Classified in: Health
Subject: PER

MMS Hires CRO Leader Lisa James as Director of Business Operations and Client Relations


DURHAM, N.C., June 13, 2018 /PRNewswire/ -- MMS Holdings Inc. (MMS) ? a leading global clinical research organization ? announced today that Lisa James has joined as Director, Business Operations and Client Relations. James brings a depth of industry and business experience, having most recently held the position as Director of Corporate Operations at Health Decisions, Inc.

 (PRNewsfoto/MMS Holdings Inc.)

In this role, James will be responsible for leading business growth initiatives, including lead generation and new client introductions through project award, and the management of all aspects of proposal and budget development. Additionally, James will play a key role in the further development of strategic partnerships in the pharmaceutical industry.

"Lisa is a detailed and metrics-driven leader known for her understanding of key issues in clinical development outsourcing, and MMS is delighted to welcome her to the leadership team," said Kelly J. Hill, Executive Director, Global Project & Account Management, MMS. "The needs of our clients change every day and Lisa's expertise and insights are needed to ensure we make timely introductions and bring practical operational and commercial solutions."

For her leadership, James was recognized by the Triangle Business Journal in 2014 with its 40 Under 40 Leadership Award and in 2015 with its Women in Business Award.

"I am incredibly excited to move into this role at MMS, and plan on making a positive impact within the company and to benefit our clients' successful development of innovative products that receive marketing approval to address unmet medical needs," James said. "Working with sponsors directly, helping them find business solutions in the areas of data management, clinical programming and biostatistics, regulatory submissions, medical writing, transparency, and other areas, is something that I very much look forward to."

James brings deep experience in partnering with biopharma and medical device companies and government organizations to her role at MMS. Prior to joining MMS, James held business operations positions at Health Decisions, Inc. and at Fulcrum Pharma Developments, Inc. which was later acquired by Aptiv Solutions and is now part of ICON plc.

MMS continues to hire key leaders in North Carolina and across the globe. For open opportunities, visit: www.mmsholdings.com/careers

About MMS
MMS is a leading global clinical research organization that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex regulatory submission challenges. As a focused, high-quality services organization, we are pioneers and leaders in regulatory submissions for our sponsors. Strong industry experience and a data-driven approach to drug development make MMS a valuable partner in creating compelling submissions that meet rigorous regulatory standards. For more information, visit www.mmsholdings.com.

Media contact
Don McLean, MBA
+1-734-245-0165
[email protected]

 

SOURCE MMS Holdings Inc.


These press releases may also interest you

at 09:38
Atlanta's premier indoor multi-sports facility, Intown Stars Training and Events Center has been honored with several prestigious awards from the Georgia Business Journal's Best of Georgia and Atlanta Magazine's Best of Atlanta awards.   Through the...

at 09:35
ReAlta Life Sciences, Inc. ("ReAlta" or the "Company"), a mid-stage clinical biotech company dedicated to saving lives by rebalancing the inflammatory response to address life-threatening diseases, today announces that the company will be utilizing...

at 09:30
Athletico Physical Therapy has opened a new location in Grand Blanc, Michigan, located across from Kroger and next to Starbucks on S. Saginaw Rd. This location offers convenient hours, including early morning, late evening and Saturday appointments,...

at 09:27
Serum Detect, a cancer diagnostics company, is debuting a novel and promising approach for cancer early detection at the...

at 09:25
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the 2023 annual results as of 31 December 2023. Financial Highlights Revenue increased by 18.1% to...

at 09:22
A unique online platform, My Yoga Journey, has been launched by Yourself Yoga for Menopause to provide yoga exclusively for women in menopause who prefer a natural solution to help alleviate their symptoms....



News published on and distributed by: